Biotricity Inc. (Biotricity) today announced its financial results for the second quarter of fiscal 2024 year and (unaudited) ended September 30, 2023. Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “In the second quarter of fiscal 2024, we continued our mission to innovate and create transformative healthcare products, all while maintaining a strong commitment to financial discipline. Our primary focus remains on driving revenue and margins and as such, we are pleased to see continued progress in achieving improvement in these metrics”.
